The a2 Milk Company Limited achieved a substantial lift in revenue and earnings in the 2016 financial year, with continued growth in the ANZ and China markets, and further progress in its targeted investment in a number of international markets.
The a2 Milk Company Limited is pleased to announce its admission to the S&P/ASX 200 Index effective after the close of trading on 17 June 2016.
Results of a human clinical trial show that A1 protein in cows’ milk may trigger symptoms of lactose intolerance. a2 Milk™, naturally free from A1 protein, potential solution for millions.
The New Zealand Government today awarded a $NZ1.15 million High-Value Nutrition research grant to AgResearch Limited to undertake research to validate the benefits of A2 beta casein protein contained in milk-based products on digestive function
The a2 Milk Company Limited is a dual listed on the NZX and ASX.
Visit our Investor Centre for up-to-date information about our company and our performance.